Fibroblast growth factor-23 is a strong predictor of insulin resistance among chronic kidney disease patients

Fibroblast growth factor 23 directly targets hepatocytes to promote inflammation in chronic kidney disease

(2016) Saurav Singh et al.   KIDNEY INTERNATIONAL

Left Ventricular Mass Progression despite Stable Blood Pressure and Kidney Function in Stage 3 Chronic Kidney Disease

(2014) Michael E. Seifert et al.   AMERICAN JOURNAL OF NEPHROLOGY

Clinical Correlates of Insulin Sensitivity and Its Association with Mortality among Men with CKD Stages 3 and 4

(2014) H. Xu et al.   Clinical Journal of the American Society of Nephrology

Insulin resistance in chronic kidney disease: a step closer to effective evaluation and treatment

(2014) Ian H. de Boer et al.   KIDNEY INTERNATIONAL

Insulin resistance is associated with Fibroblast Growth Factor-23 in stage 3–5 chronic kidney disease patients

(2013) Jocelyn S. Garland et al.   JOURNAL OF DIABETES AND ITS COMPLICATIONS

Fibroblast growth factor 23 is associated with carotid artery calcification in chronic kidney disease patients not undergoing dialysis: a cross-sectional study

(2013) Masaru Nakayama et al.   BMC Nephrology

Fibroblast Growth Factor 23 and Inflammation in CKD

(2012) J. Munoz Mendoza et al.   Clinical Journal of the American Society of Nephrology

Insulin Resistance in Patients with Chronic Kidney Disease

(2012) Min-Tser Liao et al.   JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY

Insulin resistance is a risk factor for the progression of chronic kidney disease

(2011) H. Kobayashi et al.   CLINICAL NEPHROLOGY